TemPredict

A key takeaway from the COVID-19 crisis is the need for scalable methods and systems for ingestion of big data related to the disease, such as models of the virus, health surveys, and social data, and the ability to integrate and analyze the ingested data rapidly. One specific example is the use of the Internet of Things and wearables (i.e., the Oura ring) to collect large-scale individualized data (e.g., temperature and heart rate) continuously and to create personalized baselines for detection of disease symptoms.

There is significant variability in neutralizing antibody responses (which correlate with immune protection) after COVID-19 vaccination, but only limited information is available about predictors of these responses. We investigated whether device-generated summaries of physiological metrics collected by a wearable device correlated with post-vaccination levels of antibodies to the SARS-CoV-2 receptor-binding domain (RBD), the target of neutralizing antibodies generated by existing COVID-19 vaccines.

Early detection of diseases such as COVID-19 could be a critical tool in reducing disease transmission by helping individuals recognize when they should self-isolate, seek testing, and obtain early medical intervention. Consumer wearable devices that continuously measure physiological metrics hold promise as tools for early illness detection. We gathered daily questionnaire data and physiological data using a consumer wearable (Oura Ring) from 63,153 participants, of whom 704 self-reported possible COVID-19 disease.